Mofloxin Lafrancol
Mofloxin Lafrancol Uses, Dosage, Side Effects, Food Interaction and all others data.
Mofloxin Lafrancol is a synthetic broad spectrum, flouroquinolone derivative antibacterial agent. Mofloxin Lafrancol has in vitro activity against a wide range of Gram-positive and Gram-negative microorganisms. The bactericidal action of Mofloxin Lafrancol results from inhibition of the topoisomerase II (DNA gyrase) and topoisomerase IV required for bacterial DNA replication, transcription, repair and recombination.
Mofloxin Lafrancol is a quinolone/fluoroquinolone antibiotic. Mofloxin Lafrancol can be used to treat infections caused by the following bacteria: Aerobic Gram-positive microorganisms: Corynebacterium species, Micrococcus luteus, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, Staphylococcus warneri, Streptococcus pneumoniae, and Streptococcus viridans group. Aerobic Gram-negative microorganisms: Acinetobacter lwoffii, Haemophilus influenzae, and Haemophilus parainfluenzae. Other microorganisms: Chlamydia trachomatis.Mofloxin Lafrancol is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Mofloxin Lafrancol is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria.
| Trade Name | Mofloxin Lafrancol |
| Availability | Prescription only |
| Generic | Moxifloxacin |
| Moxifloxacin Other Names | Moxifloxacin, Moxifloxacino |
| Related Drugs | amoxicillin, prednisone, doxycycline, ciprofloxacin, cephalexin, metronidazole, azithromycin, clindamycin, ceftriaxone, levofloxacin |
| Type | |
| Formula | C21H24FN3O4 |
| Weight | Average: 401.4314 Monoisotopic: 401.175084476 |
| Protein binding | 50% bound to serum proteins, independent of drug concentration. |
| Groups | Approved, Investigational |
| Therapeutic Class | 4-Quinolone preparations |
| Manufacturer | |
| Available Country | Colombia, Ecuador |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
Mofloxin Lafrancol is used for the treatment of adults (>18 years of age) with infections caused by susceptible strains of the designated microorganisms in the conditions listed below-
- Acute Bacterial Sinusitis caused by Streptococcus pneumoniae, Haemophilus infuenzae or Moraxella catarrhalis.
- Acute Bacterial Exacerbation of Chronic Bronchitis caused by Streptococcus pneumoniae, Haemophilus infuenzae, Haemophilus parainfuenzae, Klebsiella pneumoniae, methicillin-susceptible Staphylococcus aureus or Moraxella catarrhalis
- Community Acquired Pneumonia caused by Streptococcus pneumoniae (including multi-drug resistant strains), Haemophilus infuenzae, Moraxella catarrhalis, methicillin-susceptible Staphylococcus aureus, Klebsiella pneumoniae, Mycoplasma pneumoniae or Chlamydophilia pneumoniae.
- Uncomplicated Skin and Skin Structure Infections caused by methicillin-susceptible Staphylococcus aureus or Streptococcus pyogen.
- Complicated Skin and Skin Structure Infections caused by methicillin-susceptible Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae or Enterobacter cloacae.
- Complicated Intra-Abdominal Infections including polymicrobial infections such as abscess caused by Escherichia coli, Bacteroides fragilis, Streptococcus anginosus, Streptococcus constellatus, Enterococcus faecalis, Proteus mirabilis, Clostridium perfringens, Bacteroides thetaiotaomicron or Peptostreptococcus species.
Mofloxin Lafrancol is also used to associated treatment for these conditions: Acute Exacerbation of Chronic Bronchitis (AECB), Bacterial Conjunctivitis, Community Acquired Pneumonia (CAP), Plague, Postoperative Inflammatory Response, Sinusitis, Skin Infections, Ocular bacterial infections, Post-operative infection
How Mofloxin Lafrancol works
The bactericidal action of moxifloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV. DNA gyrase is an essential enzyme that is involved in the replication, transcription and repair of bacterial DNA. Topoisomerase IV is an enzyme known to play a key role in the partitioning of the chromosomal DNA during bacterial cell division.
Dosage
Mofloxin Lafrancol dosage
The dose of Mofloxin Lafrancol is 400 mg once every 24 hours. The duration of therapy depends on the type of infection as described bellow-
- In Acute Bacterial Sinusitis: Mofloxin Lafrancol 400 mg is given once daily for 10 days.
- In Acute Bacterial Exacerbation of Chronic Bronchitis: Mofloxin Lafrancol 400 mg is given once daily for 5 days.
- In Community Acquired Pneumonia: Mofloxin Lafrancol 400 mg is given once daily for 7-14 days.
- In Uncomplicated Skin & Skin Structure infections: Mofloxin Lafrancol 400 mg is given once daily for 7 days.
- In Complicated Skin & Skin Structure infections: Mofloxin Lafrancol 400 mg is given once daily for 7-21 days.
- In Complicated Intra-Abdominal infections: Mofloxin Lafrancol 400 mg is given once daily for 5-14 days.
Mofloxin Lafrancol 400 mg IV infusion can be administered intravenously for the entire treatment duration. Alternatively, therapy may be initial intravenous administration, followed by oral administration when clinically indicated. The recommended duration of treatment for the indication being treated should not be exceeded. The solution for infusion should be infused intravenously over 60 minutes.
Side Effects
The following one or more side effects may be observed: tendinopathy and tendon rupture, QT prolongation, hypersensitivity reactions, Clostridium difficile-associated diarrhea, peripheral neuropathy, photosensitivity, phototoxicity etc.
Toxicity
Symptoms of overdose include CNS and gastrointestinal effects such as decreased activity, somnolence, tremor, convulsions, vomiting, and diarrhea. The minimal lethal intravenous dose in mice and rats is 100 mg/kg.
Precaution
Mofloxin Lafrancol should be discontinued at the first appearance of a skin rash or any other sign of hypersensitivity. Mofloxin Lafrancol should be discontinued if the patient experiences pain, swelling, inflammation or rupture of a tendon.
Interaction
No quinolone should be co-administered with any solution containing multivalent cations (e.g. magnesium) through the same intravenous line. Antacids, iron and adsorbents reduce absorption of Mofloxin Lafrancol. NSAID may increase the risk of CNS stimulation. Warfarin may increase the risk of bleeding.
Food Interaction
- Drink plenty of fluids.
- Take with or without food.
Mofloxin Lafrancol multivitamins interaction
[Moderate] ADJUST DOSING INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics.
Absorption may also be reduced by sucralfate, which contains aluminum, as well as other polyvalent cations such as iron and zinc.
The mechanism is chelation of quinolones by polyvalent cations, forming a complex that is poorly absorbed from the gastrointestinal tract.
The bioavailability of ciprofloxacin has been reported to decrease by as much as 90% when administered with antacids containing aluminum or magnesium hydroxide.
When coadministration cannot be avoided, quinolone antibiotics should be dosed either 2 to 4 hours before or 4 to 6 hours after polyvalent cation-containing products to minimize the potential for interaction.
When coadministered with Suprep Bowel Prep (magnesium Please consult individual product labeling for specific recommendations.
Mofloxin Lafrancol Drug Interaction
Moderate: aspirin, aspirin, aspirin, celecoxib, albuterol / ipratropium, budesonide / formoterolUnknown: amoxicillin / clavulanate, diphenhydramine, ubiquinone, duloxetine, omega-3 polyunsaturated fatty acids, furosemide, atorvastatin, metoprolol, acetaminophen, acetaminophen, cyanocobalamin, pyridoxine, ascorbic acid, cholecalciferol
Mofloxin Lafrancol Disease Interaction
Major: colitis, liver disease, CNS disorders, myasthenia gravis, peripheral neuropathy, QT interval prolongation, tendonitisModerate: crystalluria, diabetes
Volume of Distribution
- 1.7 to 2.7 L/kg
Elimination Route
Well absorbed from the gastrointestinal tract. Absolute oral bioavailability is approximately 90%. Food has little effect on absorption.
Half Life
11.5-15.6 hours (single dose, oral)
Clearance
- 12 +/- 2 L/hr
Elimination Route
Approximately 45% of an oral or intravenous dose of moxifloxacin is excreted as unchanged drug (~20% in urine and ~25% in feces).
Pregnancy & Breastfeeding use
Pregnancy Category C. Mofloxin Lafrancol is not recommended during pregnancy & lactation.
Contraindication
Mofloxin Lafrancol is contraindicated in persons with a history of hypersensitivity to Mofloxin Lafrancol or any member of the quinolone class of antimicrobial agents and any component of this formulation.
Special Warning
Elderly: No adjustment of dosage is required in the elderly.
Children: Efficacy and safety of Mofloxin Lafrancol IV infusion in children and adolescent have not been established.
Acute Overdose
In the events of an acute overdose, the stomach should be emptied. The patient should be kept under observation and appropriate hydration should be maintained.
Storage Condition
Store between 15 to 30° C. Protect from light and moisture. Keep away from reach of children.
Innovators Monograph
You find simplified version here Mofloxin Lafrancol
Mofloxin Lafrancol contains Moxifloxacin see full prescribing information from innovator Mofloxin Lafrancol Monograph, Mofloxin Lafrancol MSDS, Mofloxin Lafrancol FDA label
FAQ
What is Mofloxin Lafrancol used for?
Mofloxin Lafrancol is used to treat certain infections caused by bacteria such as pneumonia, and skin, and abdominal (stomach area) infections.Mofloxin Lafrancol is also used to prevent and treat plague a serious infection that may be spread on purpose as part of a bioterror attack.
How safe is Mofloxin Lafrancol?
Mofloxin Lafrancol may cause problems with bones, joints, and tissues around joints in children.Mofloxin Lafrancol should not be given to children younger than 18 years old.Mofloxin Lafrancol may cause other side effects. Call your doctor if you have any unusual problems while you are taking this medication.
How does Mofloxin Lafrancol work?
Mofloxin Lafrancol works by killing the bacteria that cause infections. Antibiotics such as Mofloxin Lafrancol will not work for colds, flu, or other viral infections.
What are the common side effects of Mofloxin Lafrancol?
The common side effects of Mofloxin Lafrancol are include:
- nausea.
- vomiting.
- stomach pain.
- diarrhea.
- constipation.
- heartburn
Is Mofloxin Lafrancol safe during pregnancy?
Use is considered acceptable; according to some experts,this drug should be used during pregnancy only if the benefit outweighs the risk to the fetus.
Is Mofloxin Lafrancol safe during breastfeeding?
Use of Mofloxin Lafrancol is acceptable in nursing mothers with monitoring of the infant for possible effects on the gastrointestinal flora, such as diarrhea or candidiasis..Mofloxin Lafrancol is preferable to use an alternate drug for which safety information is available.
Can I drink alcohol with Mofloxin Lafrancol?
Do not drink alcohol. Drinking alcohol can increase the chance of liver problems while you are taking Mofloxin Lafrancol. Avoid hard physical activity. Although not common, Mofloxin Lafrancol can make it easier to get tendon injuries.
Can I drive after taking Mofloxin Lafrancol?
Do not drive or do anything else that could be dangerous until you know how this medicine affects you.
What is the best time to take Mofloxin Lafrancol?
Mofloxin Lafrancol is usually taken with or without food once a day for 5 to 21 days. The length of treatment depends on the type of infection being treated. Your doctor will tell you how long to take Mofloxin Lafrancol. Take Mofloxin Lafrancol at around the same time every day.
Can I take Mofloxin Lafrancol at night?
Take Mofloxin Lafrancol exactly as your doctor tells you to. You will be prescribed a dose of one tablet a day. Try to take the tablets at the same time of day each day, as this will help you to remember to take Mofloxin Lafrancol regularly.
Is Mofloxin Lafrancol a good antibiotic?
Normally, Mofloxin Lafrancolis not a dangerous antibiotic for most people, but in rare cases, it can cause serious side effects such as heart rhythm problems, liver damage, and tendon rupture.
Does Mofloxin Lafrancol make me sleepy?
Mofloxin Lafrancol may cause some people to become dizzy, lightheaded, drowsy, or less alert than they are normally.
Can Mofloxin Lafrancol cause blurry vision?
Mofloxin Lafrancol ophthalmic may cause blurred vision and may impair your reactions. Avoid driving or hazardous activity until you know how this medicine will affect you.
Can Mofloxin Lafrancol increase heart rate?
Mofloxin Lafrancol causes increase heart rate greater than 10 bpm.
How often can I use Mofloxin Lafrancol?
Mofloxin Lafrancol is usually used three times a day for 7 days. Try to use at around the same times every day.
Can I overdose on Mofloxin Lafrancol?
An overdose of Mofloxin Lafrancol ophthalmic is not expected to be dangerous. Seek emergency medical attention if anyone has accidentally swallowed the medication. Do not use other eye medications unless your doctor tells you to.
Can Mofloxin Lafrancol cause permanent damage?
Mofloxin Lafrancol can cause long-lasting, disabling and potentially permanent side effects involving tendons, muscles, joints and the nervous system.
How long does btrand stay in my body?
The elimination half-life of Mofloxin Lafrancol is 11.5 to 15.6 hours .About 45% of an oral or intravenous dose of Mofloxin Lafrancol is excreted as unchanged drug.
Can I take Mofloxin Lafrancol for a long time?
Mofloxin Lafrancol oral tablet is used for short-term treatment.
How long can I take Mofloxin Lafrancol?
Mofloxin Lafrancol comes as tablet to take by mouth.Mofloxin Lafrancol is usually taken with or without food once a day for 5 to 21 days. The length of treatment depends on the type of infection being treated.
Who should Mofloxin Lafrancol take Mofloxin Lafrancol?
Stop using Mofloxin Lafrancol and call your doctor at once if you have symptoms such as:headache, hunger, irritability, numbness, tingling, burning pain, confusion, agitation, paranoia, problems with memory or concentration, thoughts of suicide, or sudden pain or movement problems in any of your joints.
